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increases the LC–LE and LE–LC transition temperatures and increases the order on the disordered side of the
hysteresis loop leading to a phase of intermediate order, which could be the liquid-disordered (Ld) phase.
Cholesterol is also observed to show a preference for LC–LE domain boundaries. The results of our molecular
dynamics simulations coincide with many experimental observations and can help provide insight into the
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Lung surfactant (LS) is a mixture of phospholipids, fatty acids,
neutral lipids, and surfactant proteins that forms the surface-active
lining in the lungs and decreases the work of breathing by reducing
and regulating the surface tension in the alveoli. Lung surfactant
consists of approximately 90% lipids and 10% proteins by weight [1].
Of the surfactant lipids, about 80% are phosphatidylcholines, about
half of which is dipalmitoylphosphatidylcholine (DPPC) [1]. Infants
born prematurely lack functional lung surfactant and develop
respiratory distress syndrome (RDS). Surfactant replacements have
greatly reduced the mortality rate of RDS, but are not optimal [2].
Another form of RDS known as acute respiratory distress syndrome
(ARDS) can develop in adults and has proven difﬁcult to treat due to
complications associated with underlying lung injury [3]. ARDS is
often associated with the leakage of plasma proteins and other
molecules into the lungs, resulting in inhibited lung surfactant
function, which can be attributed to a variety of factors such as
competitive adsorption. It is well known that in order to be effective,
lung surfactant must display rapid adsorption, the ability to compressto near-zero surface tension upon end-expiration, and rapid
respreading upon ﬁlm expansion [4]. However, further research is
needed to understand the mechanisms involved and the roles of
individual surfactant components in the respiratory process, in order
to aid the development of more efﬁcient surfactant replacements to
treat both neonatal and adult RDS.
The surfactant ﬁlm undergoes rapid changes in surface area (and
surface pressure) under the dynamic cycling occurring with each
breath. Maintaining proper surfactant functionality under these
demanding conditions requires a number of components. The primary
component, dipalmitoylphosphatidylcholine (DPPC) has a high phase
transition temperature of 41 °C [5], and therefore exists in the liquid
condensed (LC) phase at body temperature. In the condensed phase
DPPC is tightly packed and can be compressed to surface pressures
well above the equilibrium spreading pressure (πe) without collapse.
For this reason DPPC is thought to be primarily responsible for the
ability of lung surfactant to reach near-zero surface tension
(high surface pressure). However, due to its rigidity at physiological
temperature, DPPC exhibits poor respreadibility [6]. Additional
surfactant components enhance the functionality of LS. Unsaturated
phospholipids, such as palmitoyloleoylphosphatidylcholine (POPC),
ﬂuidize lung surfactant surface ﬁlms increasing adsorption to the
interface and are thought to enhance respreading [1]. Neutral lipids
and fatty acids are also present, such as cholesterol (5–10 wt.% of
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is systematically removed from most surfactant replacements [7].
Lung surfactant also contains surface-associated surfactant proteins
SP-B and SP-C, which are essential tomodulate the physical properties
of the surface ﬁlm and to promote the rapid formation of surface ﬁlms
capable of reaching near-zero surface tensions under repetitive
cycling [8]. Both peptides are highly hydrophobic and amphipathic.
SP-C contains palmitoyl chains on cysteine residues 5 and 6 [9]. SP-B
contains seven cysteines, which form three intramolecular disulﬁde
bridges and an intermolecular one leading to the formation of a
homodimer [10]. SP-B contains more polar and hydrophilic residues
than SP-C and is therefore less hydrophobic. The tertiary structure of
SP-B is unknown; however the structure is known for the 25-residue
N-terminal fragment (SP-B1–25), which is thought to retain most of
the functionality of the full-length protein.
As themonolayer is compressed from a highmolecular area to a low
molecular area (low surface pressure to high surface pressure) it passes
through distinct regions of the pressure area isotherm: G, LE+G, LE,
LC+LE, LC [11]. In the gas (G) phase the lipids are very sparse and
behave like a 2D gas [12]. The liquid-expanded (LE) phase is
characterized by a ﬂuid-like structure, where the molecules are in
close contact with one another, but the lipid tails are conformationally
disordered and contain a signiﬁcant number of gauche conﬁgurations
[12]. The liquid-condensed (LC) phase is a 2D semi-crystalline phase,
which is characterized by hexagonal packing, lipid tails in the all-trans
conformation with a substantial drop in the number of gauche defects,
and decreased lateral mobility [12]. The formation of the LC phase
results in the lengthening of the chains and thus a thicker monolayer.
Upon compression the monolayer passes through two regions of phase
coexistence (LE–G and LC–LE). In this paper, we will focus on LC–LE
phase transitions at low surface tension (high surface pressure).
Physiologically relevant surface tensions are in the range of
0–22 mN/m [5]. In mixed lipid and lipid–peptide monolayers, portions
of the monolayer remain in the LE phase at these high surface
pressures. In fact, LC and LE coexistence can persist in surfactant ﬁlms
at near-zero surface tensions and during reversible partial collapse
transitions [13]. Several experimental studies have provided clear
microscopic evidence of the coexistence of LC and LE phases in model
surfactant monolayers, proving the existence of both micro-scale and
nano-scale domains [4,14–18].
It is not fully understood how monolayers respond to the large
changes in surface area, which occur during breathing. Neither the
structural transitions involved nor the roles of each surfactant
component are entirely clear. For example, the mechanism by
which lung surfactant is able to avoid irreversible collapse under
near-zero surface tensions remains a matter of great debate. The
ability of lung surfactant to be rigid enough to sustain near-zero
surface tension and yet ﬂuid enough to respread rapidly, seems
contradictory. This dichotomy, has lead to classical “squeeze-out”
theory [19–21], which suggests that as the monolayer undergoes
compression the surface is reﬁned by the selective squeeze-out of
non-DPPC components leaving behind amonolayer highly enriched in
DPPC. Squeeze-out theory has since been reﬁned to incorporate the
existence of a peptide-promoted surface-associated surfactant reser-
voir, in which squeezed-out material can be stored for respreading
upon expansion [22,23].
Recently, alternative theories have been proposed, such as the
theory of “supercompression” [24–27]. It is known that to reach the
near-zero surface tensions existing in the lungs the alveolar liningmust
compress past the equilibrium spreading pressure, and is thus by
deﬁnition meta-stable. The effective viscosity of the alveolar ﬁlm
controls the rate at which the ﬁlm ﬂows into the bulk phase in response
to the thermodynamic driving force [26]. It is therefore thought that to
avoid collapse the monolayer must undergo a transition to a highly
viscous material. According to Hall and co-workers [24–27] this can be
achieved by the transformation of themonolayer into either a solid-likeLCphase, as suggested by classical “squeeze-out” theory, or into a super-
compressed ﬂuid phase. Hall and co-workers have shown that both calf
lung surfactant extract (CLSE) monolayers and monolayers of the pure
POPC (an unsaturated phospholipid) can reach near-zero surface
tensions if compressed quickly enough (super-compression) [24–27].
Such a super-compressed ﬂuid maintains the high disorder of the ﬂuid
phase, but attains the resistance to ﬂow that characterizes a solid.
In a recent review, Zuo et al. [2] provide an alternative interpretation
of supercompression, suggesting that rapid compression facilitates the
formation of nanodomains rather than microdomains, which take
longer to assemble. It has been suggested that the ﬁnely divided nano-
domain structure may act as an alloy or composite material, imparting
both ﬂexibility and stability to the ﬁlm [2,4]. Furthermore, the nano-
domain structure may enhance the homogeneity of partial collapse,
which is initiated at domain boundaries [4]. Such partial collapse
structures could provide additional stability to the surfactant ﬁlm [2].
In order to begin to address the fundamental uncertainties
regarding lung surfactant mechanics, an understanding of the
interfacial structure of model surfactant mixtures is necessary. The
phase state of a surfactant monolayer will determine the mechanical
properties of themonolayer, and thus how themonolayer responds to
the dynamic compression and expansion cycles occurring during
respiration. The mechanism of collapse depends on the phase
morphology, which is determined by the temperature, surface
pressure, composition, and compression rate. For example, Gopal
and Lee [28] showed that for a 7:3 DPPC/POPG monolayer at low
temperatures (below 28 °C) the monolayer is biphasic and collapses
by forming reversible large-scale folds (up to millimeters in length),
while at high temperatures (above 33.5 °C) the monolayer is
homogenous and collapses by forming micron-scale vesicular struc-
tures, and at intermediate temperatures (28–33.5 °C) collapse occurs
by forming both folds and vesicles. Lee and co-workers [29–31]
suggest that coexistence of LC and LE phases is an essential feature
required for reversible collapse via a macroscopic folding transition.
They propose that the coexistence of LC and LE phases provides the
monolayer enough ﬂexibility to bend and enough cohesiveness to
prevent loss of material to the subphase. Partial collapse transitions in
phospholipidmonolayers also appear to require the coexistence of the
LC and LE phases [29,32].
The composition of the ﬁlm tunes the phase behavior. ARDS is
associated with a change in the composition of LS resulting in
surfactant inhibition. ARDS is often associated with the leakage of
serum proteins into the lungs following lung injury [33–35]. An
increase in cholesterol concentration can also inhibit lung function;
see [36] and references therein.
Because the phase (or phase coexistence) of the monolayer
determines the properties of the monolayer such as minimum surface
tension, collapse mechanism, reversibility of collapse, and respread-
ability of the monolayer upon expansion, an understanding of how
lung surfactant components affect phase behavior at high surface
pressures is important to the rational design of surfactant replace-
ments. To this end, here we study LC–LE phase transitions for DPPC
monolayers and monolayers of DPPC with additional LS components.
Previous CG-MD simulations have studied the role of surfactant
components on the collapse behavior of disordered monolayers [37].
Historically, lipid phase transitions have proven difﬁcult to
simulate, requiring length and time scales not attainable by atomistic
simulation. However, recent papers [38,39] have shown that it is
possible to simulate the formation of small LC nuclei via atomistic
simulation. Such simulations are computationally expensive however.
Therefore, these simulations have been limited to pure DPPC mono-
layers and to relatively short time scales, preventing the study of the
phase transition process in much detail.
In recent years, the development of coarse-grained models has
allowed the simulation of longer length and time scale events. One
popular CG force ﬁeld, the MARTINI model [40,41], is parameterized
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the simulation of a wide variety of lipid and lipid/peptide systems,
some of which are discussed in a recent review [42]. Another notable
CG force ﬁeld was recently developed by Shinoda et al. [43]. This force
ﬁeld gives a pressure-area isotherm for DPPC monolayers closely
resembling the experimental isotherm of Crane et al. [44] and
successfully reproduces liquid crystalline bilayer properties such as
area per lipid, area expansion modulus, and molecular distributions
providing excellent agreement with experiment and atomistic
simulation results. Shinoda et al. further demonstrated the utility of
the CG-MD approach by performing simulations of bilayer self-
assembly, monolayer collapse, and vesicle formation [43]. For a
review of additional coarse grained models applied to lipid systems
see [42].
Utilizing an early version of their MARTINI force ﬁeld [45], Marrink
et al. [46] applied CG-MD to the study of gel–liquid-crystalline phase
transitions in DPPC bilayers. The line tension estimated with the
MARTINI model was found to be in good agreement with the
experimental value, and gel and ﬂuid lateral diffusion rates from
MARTINI were within the rather large error bars (factor of 10) of
experimental estimates [46]. This work showed that the MARTINI
model could successfully be applied to the study of lipid phase
transitions. A recent study by Laing et al. [47] applied the MARTINI
model to the simulation of 8:2:1 and 4:1:4 DPPC:POPG:cholesterol
monolayers at 310K and surface tensions of 0, 20, and 40 mN/m.
Although this study reported evidence of the formation of a
condensed phase at elevated cholesterol concentrations, it was
limited to small monolayers of 33–36 lipids each and did not focus
directly on the phase transition process itself. The formation and
coarsening of LC phase domains in DPPC monolayers have also been
modeled using kinetic modeling [48]. To the best of our knowledge,
MD simulation has yet to be applied to a detailed study of phase
transitions in multicomponent lipid monolayers. Here we apply the
MARTINI coarse-grained model [40,41] to the study of LE–LC phase
transitions in DPPC monolayers, and phase transitions in mixed
monolayers containing DPPC with additional lipid and peptide
components. Although the MARTINI model has been found to exhibit
unrealistic behavior at high areas per lipid [43], it gives reasonable
results for densely packed interfaces as studied here.
In the LC phase DPPC molecules tilt at an angle of 25° with respect
to the normal [12]. This tilt is due to a mismatch between the
minimum cross-sectional area of 50 Å2 for the head group and 38 Å2
for both of the phospholipid tails combined [12]. For this reason the
term tilted condensed (TC) is often used to describe the liquid
condensed phase of monolayers containing DPPC. Although the tilted
condensed phase is often discussed experimentally, all results
reported here are for the untilted condensed phase. Because the
MARTINI model implicitly incorporates some of the tail entropy of the
lipid tails into the volume of the CG interaction sites, the DPPC
molecules do not form the tilted condensed phase [46].
It has been suggested that non-equilibrium phase transitions should
not be called “phase transitions”, but instead should be referred to as
“phase transformations”. Since the terminology “phase transition” is in
the experimental literature, we will therefore retain this terminology.
However, it is important to note that the phase transitions observed
here are distinctly non-equilibrium. Monolayers at high surface
pressures (low surface tension) are in a metastable state and are thus
inherently non-equilibrium structures. Furthermore, the true equilibri-
um between phases in the monolayer is established very slowly, as
indicated by the dependence of experimental phase distributions on the
rate of compression [4].
2. Simulation methods
The MARTINI CG model [40,41] was used in all simulations
reported here. The CG mapping of DPPC, cholesterol, sodium ions,chloride ions, and water molecules is the same as that provided in the
topology ﬁles on the MARTINI website [49]. The Perl script
seq2cgtop_martini_v2.1tryout.pl [49] was used to generate the
topology for coarse-grained SP-B1–25 and SP-C. The structure ﬁles
for SP-B1–25 and SP-C were created by coarse-graining structure ﬁles
for SP-B1–25 [50] and SP-C [51] that were obtained by FTIR and NMR
spectroscopy. The MARTINI model is parameterized based on
thermodynamic data, and has successfully reproduced membrane
properties such as area per lipid [45,40], pressure-area isotherms [11],
gel–liquid-crystalline phase transitions in bilayers [46], phase transi-
tions between lamellar and non-lamellar phases [52,53], self assembly
of bilayers, and structural and dynamic features of protein–lipid
interactions [41]. Furthermore, the MARTINI model yields proﬁles of
lateral pressure versus vertical position in the monolayer that are
qualitatively similar to those obtained from atomistic simulations,
suggesting that the MARTINI model captures the essential lipid/
solvent properties [54].
Each conﬁguration was constructed from two disordered lipid
monolayers (each composed of 256 DPPC molecules) placed
with heads facing each other across a layer of water, and tails
separated by vacuum, in a periodic box, as described previously [11].
The z-dimension, normal to the layers, was adjusted to 100 nm, which
allows more than enough space to prevent interaction of the tail
regions of the two monolayers. In DPPC/SP-B1–25 monolayers, the
SP-B1–25 molecules were then placed in each monolayer, oriented
normal to the interface with the insertion sequence, which is the last
eight residues on the N-terminus side, placed close to the head group
region. During the ﬁrst few nanoseconds of simulation, SP-B1–25
moves into the interface, and adopts a ﬁnal orientation that is parallel
to the interface, as observed previously [37]. Four peptides were
inserted into each monolayer in three initial conﬁgurations: 1) with
the peptides clustered together (not in contact, but with each
peptide ~1.7 nm from the center of the box), 2) in a line (separated
by ~3.3 nm), and 3) in a square (with each peptide placed ~4.5 nm
from the center of the box). CG chloride ions were added to make the
system electroneutral. The system was then energy minimized.
In DPPC/SP-C monolayers, SP-C was placed in the monolayer in the
line conﬁguration as described above for SP-B1–25, but with the
α-helix placed initially embedded in the lipid tail region and tilted
with respect to the interface. The SP-C molecules were initially placed
differently that the SP-B1–25 molecules to account for differences in
the experimental orientation of the two peptides in DPPCmonolayers.
SP-B is thought to reside near the headgroup region with its α-helix
parallel to the interface [55]. However, SP-C is highly hydrophobic and
infrared reﬂection–adsorption spectroscopy has revealed that SP-C
adopts a tilted orientation, embedded within DPPC monolayers [56].
The simulated peptide concentrations were roughly 6 and 8 wt.% for
SP-B1–25 and SP-C, respectively.
The CG topology and structureﬁles for POPCwere adapted from the
lipid topology and palmitoyloleoylphosphatidylethanolamine (POPE)
bilayer CG structure ﬁles taken from the MARTINI website [49], by
replacing the ethanolamine head group bead (Qd)with a choline head
group bead (Q0). A system containing two POPC monolayers was
constructed in the same way as described above for the DPPC
monolayers. Then to create 1:1 DPPC:POPC monolayers, POPC
molecules were randomly replaced with DPPC molecules to obtain a
1:1 mixture and the systemwas then energy minimized. To create the
DPPC/cholesterol monolayers, 50 cholesterol molecules were ran-
domly inserted into each DPPC monolayer and the system was then
energy minimized. The resulting monolayer contained roughly the
same proportion of cholesterol to DPPC as in lung surfactant and
was ~9 wt.% cholesterol. The topology used for cholesterol is the same
as that reported on theMARTINI website [49]. The CG structure ﬁle for
cholesterol was created by coarse-graining the ﬁrst of eight atomistic
structures for cholesterol (molecule A) obtained via X-ray diffraction
by Shieh et al. [57].
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Berendsen thermostat [58] with a 1 ps time constant. Berendsen
pressure coupling was used with a 1 ps time constant and all
compressibilities set to 5E−6 bar−1. Pressure was coupled aniso-
tropically to 0 bar in all directions (zero surface tension). The surface
tension is calculated from the following equation [59]:
γ tð Þ = Lz
2
Pzz tð Þ−
Pxx tð Þ + Pyy tð Þ
2
 
ð1Þ
where t is time, Lz is the length of the box in the z-direction, and Pxx,
Pyy, and Pzz are the pressures in the x, y, and z directions. As noted
previously [37], due to pressure ﬂuctuations the actual time-average
surface tension differs slightly from this set point. For more details on
each couplingmechanism the reader is referred to the GROMACS User
Manual [60] and relevant simulation papers [61–65]. For all
simulations, a timestep of 0.02 ps was used, and periodic boundary
conditions were employed. All simulations were performed using
GROMACS simulation software [66–68]. The following parameters
were taken from the MARTINI website [49] and have been optimized
for the coarse grained model: short-range electrostatic and van der
Waals cutoffs of 1.2 nm, with van der Waals interaction shifting
smoothly to Lennard Jones interaction at 0.9 nm. The neighbor list was
updated every 10 steps using a grid with a 1.2 nm cutoff distance.
In addition to the large computational speed-up, the molecular
diffusivities of CG water and lipid molecules are around four times
higher than for atomistic ones. As a result, the effective time of a
simulation is roughly four times longer than the “physical” time [40].
However, all times reported here are physical times, as reported by
the simulation.
After energy minimization the initial conﬁgurations (described
above) were equilibrated for 1 μ s at high temperature (338K for all
peptide-free monolayers, and 333K for peptide-containing mono-
layers). The ﬁnal conﬁgurations from these runs were used as starting
states for 1 μ s runs at low temperature (283K for all systems), to
allow each monolayer to order. The ﬁnal conﬁgurations of the high
and low temperature runs were used as initially disordered and
initially ordered starting conﬁgurations for subsequent runs, which
were performed between 283K and 338K in 5K increments.
A program called Triangle was used to perform a Delaunay
reﬁnement on the simulation trajectories [69]. From the Triangle
output ﬁles condensed phase lipids can be identiﬁed. The output ﬁles
from Triangle were converted into an index ﬁle containing only the C2
tail sites that are considered to be in the liquid-condensed phase.
Marrink et al. developed the following criteria: in order to be in the
condensed phase (gel phase for bilayers) the C2 tail sites of a lipid
must be six coordinated, corresponding to hexagonal packing, and
must have ﬁve of its six neighboring C2 sites less than 0.75 nm away
[46]. The second criterion is used to eliminate lipids that are six
coordinated, but deviate considerably from hexagonal packing [46].
We used the same criteria in our analysis, except we tightened the
second restraint to require that all six C2 sites be within 0.75 nm. This
was done to limit noise in our data, which appeared as a few isolated
C2 sites. In monolayers containing DPPC and POPC, the C2 sites of both
phospholipids were used in the calculation of the percentage of
hexagonally packing. In monolayers containing cholesterol, the R3
beads of the cholesterol molecules are treated as neighboring C2 sites
in order to determine the extent of hexagonal packing for DPPC.
However, the reported percentage of hexagonal packing is only
calculated for the C2 sites of the phospholipids. The R3 beads of
cholesterol were chosen as neighboring sites for the hexagonal
packing analysis because they lie in the roughly the same xy-plane as
the C2 sites of DPPC.
The simulation trajectories of the 1 μ s runs were saved for packing
analysis every 1 ns. Shorter (100 ns) runs are also reported for DPPC
monolayers to assess artifacts attributed to simulation time. To allowmore data points for packing analysis, the trajectories of these shorter
runs were saved for packing analysis every 0.2 ns. The percentage of
hexagonal packing was averaged between 500 ns and 1 μ s for the 1 μ
s runs and between 50 ns and 100 ns for the shorter runs. For the
longer time-scale runs there are a couple of cases where the transition
from disordered to ordered phase or vice-versa occurs late in the
simulation (after 500 ns); for these runs the hexagonal packing was
averaged after the transition was complete, between 900 ns and 1 μ s.
The error bars reported on the hysteresis loops represent the standard
deviation.
The simulations of DPPC monolayers yielded a large hysteresis
loop with respect to temperature. In order to estimate the true
transition temperature and study the growth of the ordered and
disordered phases, the ﬁnal conﬁgurations resulting from 1 μ s
simulations of initially ordered and initially disordered DPPC
monolayers at 308K were merged together. As the monolayers
condense the lateral dimensions of the monolayer decrease and the
thickness increases. This transformation results in a thicker (larger in
the z-dimension) water subphase in the system containing ordered
monolayers. Therefore, to allow the ordered and disordered mono-
layer to align, a small water box containing 993 CG water molecules
was inserted in the disordered box between the top monolayer and
the original water subphase. The disordered and ordered boxes were
then placed side by side in the x-dimension. A small ~0.7 nm
mismatch between the monolayers in the y-dimension remained. To
account for this mismatch two different systems were constructed,
which we will call Merge1 and Merge2. In Merge1 the dimensions of
the disordered box were shrunk by 0.7 nm, effectively compressing
the disordered box slightly. Another conﬁguration (Merge2) was
generated where the larger y-dimension was kept, effectively
disrupting the packing in the ordered system along the edge of the
box where 0.7 nm of empty space is added. These systems containing
side by side ordered and disordered regions were energy minimized
and run at temperatures falling within the region of hysteresis
(between 303K and 323K) for 100 ns. The coordinates were output to
the trajectory every 10 ps to allow the growth or disappearance of the
condensed phase to be captured in greater detail.
3. Results and discussion
3.1. Phase transitions in DPPC monolayers and binary monolayers
containing DPPC
Here we investigate ordering and disordering transitions in DPPC
monolayers and binary monolayers composed of DPPC with SP-B1–25,
POPC, and cholesterol. For each monolayer, 1 μ s simulations were
performed at high (338K for all peptide-free monolayers, and 333K for
peptide-containing monolayers) and low (283K) temperature. The
resulting ordered (LC) and disordered (LE) conﬁgurations (after 1 μ s)
were used as the starting states for subsequent simulations. Simulations
were then run between 283K and 338K in increments of 5K from both
disordered and ordered starting conﬁgurations. The disordered starting
conﬁgurations contain a few isolated sites and small patches that meet
the criteria of being hexagonally packed (Fig. 1, top). However, these
isolated “ordered” sites do not constitute a true ordered phase. It should
also be noted that within the simulation time-scale the monolayers do
not become fully ordered. There are small defects in the packing
(disclinations) even in the ordered starting conﬁgurations obtained
after 1 μ s at 283K (Fig. 2, top).
As the temperature is decreased from the disordered (high
temperature) starting state to lower temperatures the formation and
growth of the condensed phase are evident (Fig. 1). At a system-
dependent temperature the LE–LC phase transition occurs. At the
transition temperature, each monolayer displays the coexistence of
ordered and disordered patches after 20 ns of simulation (Fig. 1,
middle), and the existence of a defect-containing LC phase at the end of
(a) (b) (c) (d)
(e) (f) (g) (h)
(i) (j) (k) (l)
Fig. 1. Ordering phase transitions in DPPC, DPPC/SP-B1–25, DPPC/POPC, and DPPC/cholesterol monolayers (from left to right) quenched from high temperature initially disordered
monolayers. The monolayers shown are quenched to the following temperatures: DPPC (303K), DPPC/SP-B1–25 (303K), DPPC/POPC (283K), and DPPC/cholesterol (313K). The snapshots
shown correspond to 0 ns (top), 20 ns (middle), and 1 μs (bottom). Ordered phospholipid C2 sites are shown in green, disordered phospholipid C2 sites are shown in blue, peptides are
shown in yellow, and cholesterol is shown in red. In 1:1 DPPC/POPC monolayers all disordered phospholipid C2 sites are shown in blue and ordered phospholipid C2 sites are shown in
green (DPPC)and red (POPC). This coloring scheme is also used in subsequentﬁgures. Ineachsystem,both the top andbottommonolayersbehave similarly. For clarity, onlyonemonolayer
is shown in each snapshot, with periodic images included.
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(Fig. 1, left), undergo a transition to the LC phase. The DPPC/SP-B1–25
monolayers are also observed to undergo an ordering transition at 303K
(Fig. 1, center left). Here, the peptides loosely aggregate and localize
within a single LEphasedomain. Away fromthepeptides themonolayer
is in the LC phase with a few small defects. In 1:1 DPPC:POPC
monolayers, due to the high concentration of unsaturated phospholipid
the ordering transition is observed at lower temperatures. When an
initially disordered 1:1 DPPC:POPC monolayer is quenched to 283K
(Fig. 1, center right), themonolayer orders and a singlepatchof LEphase
remains (alongwith its periodic replicas in Fig. 1). Once ordering occurs,
the LC phase consists of both DPPC and POPC, in similar proportions.
Within the LC phase some separation between the two components is
evident, the saturated (green) and unsaturated (red) components
cluster together, but do not completely demix. We did not observe any
segregation of the DPPC and POPC within the LE phase. Upon the
reduction of the temperature to 313K, DPPC/cholesterol monolayers
(Fig. 1, right) order with small patches of LE phase remaining at the end
of the simulation. Cholesterol packs well within the LC phase and does
not perturb the packing of the surrounding lipids. Cholesterol also
appears to exhibit a preference for the interfacebetweendisordered and
ordered lipids.To examine the disordering transition the temperature is increased
for eachmonolayer starting from a low temperature ordered state with
defects (Fig. 2). As the temperature is increased to 323K, the pure DPPC
monolayers undergo a transition to the LE phase with isolated LC
patches remaining (Fig. 2, left). A similar transition is observed in DPPC/
SP-B monolayers at 308K (left center), 1:1 DPPC:POPC monolayers at
298K (right center), and DPPC/cholesterol monolayers at 328K (right).
In all of the monolayers the transition to the LE phase appears to occur
by melting originating from defects in the monolayer. In other words,
the small disordered regions of themonolayer, such as those associated
with the presence of nearby peptides, grow at the cost of the
surrounding LC phase lipids. In the DPPC/cholesterol monolayers,
cholesterol shows a clear preference for the interface over the
disordered phase. Even when there is more LE phase present,
cholesterol is rarely surrounded entirely by disordered lipids, but
instead tends to reside at the interface between ordered and disordered
lipids.
In Fig. 3, the side views of LE (a) and LC (b) phase DPPC
monolayers are shown. The ordering transition leads to longer,
straighter chains and thus a thicker monolayer. From Fig. 3(b), the
alignment of the chains in the LC phase, due to hexagonal packing, is
clearly visible. For brevity only pure DPPC monolayers are shown.
(a) (b) (c) (d)
(e) (f) (g) (h)
(i) (j) (k) (l)
Fig. 2. Disordering phase transitions in DPPC, DPPC/SP-B1–25, DPPC/POPC, and DPPC/cholesterol monolayers (from left to right) started from low temperature initially ordered
monolayers. Themonolayers shown are run at the following temperatures: DPPC (323K), DPPC/SP-B1–25 (308K), DPPC/POPC (298K), and DPPC/cholesterol (328K). The snapshots shown
correspond to 0 ns (top), intermediate time (middle), and 1 μs (bottom). Intermediate snapshots were taken at 700 ns, 100 ns, 840 ns, and 220 ns for the DPPC, DPPC/SP-B1–25, DPPC/
POPC, and DPPC/cholesterol monolayers, respectively.
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transition.
3.2. Hysteresis loops
For each simulation, the percentage of hexagonal packing was
averaged between 500 ns and 1 μ s, with data sampled every 1 ns, and
graphed versus temperature in order to obtain hysteresis loops (Fig. 4),
where a 1 μ s run was performed at each temperature of the hysteresis
loop. In each system, the results for the top and bottom monolayers
were averaged together. The hysteresis loops obtained for the DPPC(a) (
Fig. 3. A side view of disordered and ordered DPPCmonolayers. The snapshots shownwere ta
The DPPC tails, headgroups, and glycerol linkages are shown in turquoise, dark blue, and grmonolayers are compared to the hysteresis loops obtained for DPPC/SP-
B1–25 (a), DPPC/POPC (b), and DPPC/cholesterol (c) monolayers.
In the pure DPPC monolayers phase transitions are observed
between 303K and 323K. This range of temperatures is consistent
with the experimental main phase transition temperature for DPPC
bilayers of 314K [5]. In the pure DPPC monolayers, the originally
disordered system orders between 308K and 303K and the originally
ordered system becomes disordered between 318K and 323K.
Comparing the observed ordering and disordering transition temper-
atures of pure DPPCmonolayers, substantial hysteresis is evident. This
hysteresis is decreased by the addition of a second component. Whileb)
ken after initially disorderedmonolayers were run for 1000 ns at 338K (a) and 303K (b).
een, respectively. CG water molecules are shown as small white dots.
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Fig. 4. Hysteresis loops showing the change in the percentage of hexagonally packed phospholipid C2 tail sites versus temperature for monolayers composed of DPPC (black circles)
and monolayers composed of binary mixtures of DPPC with another lipid or peptide component (red squares). The binary mixtures consist of: DPPC/SP-B1–25 (a), DPPC/POPC
(b), and DPPC/cholesterol (c). The error bars shown represent the standard deviation in the percentage of hexagonal packing at each point.
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addition of SP-B1–25 abolishes the ordered side of the hysteresis loop
altogether (Fig. 4(a)). This suggests that SP-B1–25 effectively nucleates
disorder in the monolayer. In addition, SP-B1–25 also perturbs the
packing of the surrounding phospholipids, shifting the ordered side of
the hysteresis loop to lower percentages of hexagonal packing.
In Fig. 4(b), the addition of POPC to DPPC monolayers to create a
randomly mixed 1:1 monolayer, leads to a substantial drop in the
hysteresis loop to lower temperatures (288–298K). This result is not
surprising, since unsaturated phospholipids have low transition
temperatures in comparison to saturated phospholipids. Pure POPC
bilayers have a main transition temperature of ~270K [70]. Thus, the
transition temperatures observed here fall between the main transition
temperatures of pure DPPC and pure POPC bilayers. On the length and
time-scales of the simulations reported here, the presence of POPC
spread throughout the monolayer prohibits the DPPC condensed phase
domains from nucleating at higher temperatures. Once the ordered
phase forms, bothDPPC andPOPC condense in similar proportions. After
the LCphase forms, a larger amountof LEphase remains in the1:1DPPC:
POPC monolayers than in the pure DPPC monolayers as evident by the
shift in the ordered side of the hysteresis loop to lower percentages of
hexagonal packing.
In Fig. 4(c), the hysteresis loop for DPPC/cholesterolmonolayers has
shifted up slightly (323–328K) compared to the hysteresis loop for pure
DPPC, suggesting that the addition of cholesterol has resulted in an
increase in the transition temperature and the stabilization of the
ordered phase. In addition, the disordered region of the hysteresis loop
becomes more ordered (shifts right) upon the addition of cholesterol.
This suggests that the DPPC–cholesterolmixture is displaying a phase of
intermediate order, which could be the so-called “liquid-disordered”
(Ld) phase. There is no signiﬁcant difference between the ordered sides
of the hysteresis loops for DPPC and DPPC/cholesterol monolayers.
3.3. Area per lipid and transition temperature
The simulated LC phase DPPC monolayers reported here give areas
per lipidnear0.48 nm2/molecule, as reportedpreviously [11]. This value
falls within the range of experimental areas per lipid reported for gel
phase DPPC bilayers of 0.479–0.523 nm2/molecule [71] and agrees well
with the reported range of experimental LE–LC plateaus in DPPC
monolayers, but is larger than the limiting area of DPPC of 0.39 nm2/
molecule [72]; see reference [11] for review. This value is also
comparable to the smallest values reported by Mohammad-Aghaie et
al. [39] in their atomistic simulations of LC phase nucleation in DPPCmonolayers, which were as low as 0.462 nm2/molecule. The MARTINI
model has also been reported to produce ﬂuid phase bilayers with areas
per lipid that are in agreement with experimental values [46]. An LE
phase pressure-area isotherm [11] attained using an early version of the
MARTINImodel was found to agreewell with an experimental LE phase
isotherm obtained by Crane et al. [44] using the captive bubble
apparatus. It is however problematic to compare simulated isotherms
with experimental ones. Experimental isotherms can vary greatly
depending on experimental conditions such as type of apparatus,
spreading solvent, and compression rate, therefore complicating
comparison of simulated and experimental isotherms; see reference
[11] for review. However, for completeness some comparison is
warranted. Therefore, the area per lipid was also calculated from the
DPPCmonolayer simulations, allowing isobars to be plotted. In Fig. 5(a)
the simulated isobars are compared with the experimental isobars of
Crane et al. [44] at surface pressures of 10, 40, and 65 mN/m. The
simulated isobars agree well with the 40 mN/m experimental isobar,
which falls in the middle of the simulated hysteresis loop. The surface
tension of water measured by the MARTINI model is 30 mN/m [40],
which is much lower than the actual surface tension of water. If we use
the surface tension of water calculated by the MARTINI model the
surface pressure in our zero surface tension simulations would
correspond to 30 mN/m. Therefore, the similarity between our
simulated isobars and Crane's 40 mN/m isobar is reasonable. In
Fig. 5(b) the simulated DPPC and DPPC–cholesterol isobars are
compared. The DPPC–cholesterol isobars are shifted to lowermolecular
areas than the DPPC isobars, with a relatively small deviation in the LC
region and a larger deviation in the LE phase. This result agrees
qualitativelywith the observations reported by Blume andHillmann for
DMPCandDMPC cholesterolmonolayers [73],which showadecrease in
area per molecule with increasing cholesterol concentration with a
much larger change in the molecular area for the LE phase than the LC
phase. The observed behavior can be explained by a combination of the
relatively smaller size of cholesterol, which shifts the area per lipid
down for both the LE an LC phases, and the condensing effect of
cholesterol on the LE phase.
It was found that for DPPC bilayers the macroscopic transition
temperature estimated using the MARTINI model was 295±5K [46],
which is lower than the experimental phase transition for DPPC bilayers
of 314K [5]. However, DPPC and DMPC are modeled the same in the
MARTINI model, due to the coarse grained nature of the model, and the
temperature observed in the simulations falls between the experimen-
tal transition temperatures of DPPC andDMPC. Inmonolayers the phase
transition temperature depends not only on composition, but also on
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Fig. 5. DPPC and DPPC/cholesterol isobars. (a) Isobars obtained from the DPPCmonolayer simulations reported here are compared to experimental DPPC isobars at surface pressures
of 10, 40, and 65 mN/m. (b) Isobars are compared for simulated DPPC and DPPC/cholesterol monolayers.
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lowermolecular area, the transition temperature increases with surface
pressure [26].Melting temperatures of 321–328Khavebeen reportedby
Yan et al. [26] for highly compressed DPPC monolayers; well above the
main transition temperature of the bilayer. Themelting side of theDPPC
hysteresis loop reported here shows a transition between 318K and
323K, in good agreement with the experimental temperature range
reported by Yan et al. However, consistent with previous DPPC bilayer
simulations, the estimatedmacroscopic phase transition predicted from
the simulated DPPC monolayers is lower than this experimental range.
As the system size and simulation time are increased the ordered
(melting) side of the hysteresis loop shifts to lower temperatures. As
detailed later in this paper, the true (macroscopic) phase transition
temperature is likely near 313K–315K.
3.4. Lipid components
In addition to DPPC, lung surfactant contains many other lipid
components which are important to surfactant function. Unsaturated
phospholipids, such as POPC, ﬂuidize lung surfactant surface ﬁlms,
increasing adsorption to the interface and are thought to enhance
respreading [1]. In lung surfactant, the ordered phase is thought to be
enriched in DPPC and cholesterol, while the disordered phase is thought
to be enriched in unsaturated phospholipids and surfactant proteins [7].
In the randomly mixed 1:1 DPPC:POPC monolayers studied here,
substantial enrichment of either component in the LE (or conversely LC)
phase is not observed. It appears that in the monolayers of 1:1 DPPC:
POPC there are too many POPC molecules spread evenly throughout
simulated monolayer to allow the DPPC molecules to nucleate a
condensed phase region at temperatures above the point where POPC
is also able to form a condensed phase. Therefore 1:1 DPPC:POPC
monolayers undergo the LC–LE phase transition at much lower
temperatures than the pure DPPC monolayers, with the monolayer
remaining disordered at temperatures as low as 293K.
Within the LC phase some separation between the DPPC and POPC
components is evident; the saturated (green) and unsaturated (red)
components cluster together, but do not completely demix (Fig. 6).
In contrast the LE phase always remains well mixed (not shown).
In Fig. 6(b–d) radial distribution functions (RDFs) are given for an
initially disorderedmonolayer quenched to 283K (corresponding to the
system shown in Fig. 6(a)) for DPPC–POPC(b), DPPC–DPPC (c), and
POPC–POPC (d). The height of the ﬁrst peak is bigger in the DPPC–DPPC
and POPC–POPC RDFs then in the DPPC–POPC RDFs, indicating a closer
association of DPPC and POPC with themselves than with each other.
TheRDFs are averaged overﬁve time intervals: 0–10 ns (blue), 10–50 ns
(green), 50–100 ns (yellow), 150–200 ns (red), and 900–1000 ns(black). In all three RDFs, there is a clear increase in order and in the
height of the ﬁrst peak at later times compared to the ﬁrst time interval
(0–10 ns), but this increase quickly saturates at times beyond around
10 ns. However, in a larger system size simulation containing 1024
lipids per monolayer, at 283K, a larger domain of ordered POPC was
evident (Fig. 7).
The observed coexistence between ordered DPPC and ordered
POPC domains is not likely to be physiological, since POPC has a low
transition temperature and is expected to be in the disordered phase
at physiological temperatures. Given longer length and time scales,
one would expect POPC and DPPC phase separation, allowing DPPC to
condense without a substantial proportion of POPC also condensing.
Although the simulation results reported here for DPPC/POPC mono-
layers are unphysiological, the addition of unsaturated phospholipids
to membranes has been observed to reduce the transition tempera-
ture below that of pure DPPC [7], as observed here.
Cholesterol is another important component of lung surfactant,
comprising about 5–10 wt.% of natural surfactant [7]. Experimental
results show that the removal of cholesterol fromnative lung surfactant
has a dramatic effect on the lateral structure and spreading properties of
the lung surfactant ﬁlm [74]. However, cholesterol is systematically
removed from some surfactant replacements to enhance stability [7].
Conclusions about the role of cholesterol in surfactant function have
been contradictory and a clear understanding of the cholesterol's role
remains elusive. The effect of cholesterol on phase behavior appears to
have a strong dependence on the composition, with both the amount of
cholesterol present and the presence of additional components such as
unsaturated phospholipids and surfactant having an effect. Also, phase
behavior is known to depend strongly on experimental conditions such
as rate of compression and the presence of ions. Thus, contradictory
conclusions about the role of cholesterol are likely attributed in part to
variation in experimental conditions. Although various theories have
been proposed to explain the effects of cholesterol on the phase
behavior of phospholipid bilayers and monolayers, it is generally
accepted that cholesterol modulates the phase behavior of surfactant
membranes by disordering phospholipids in the LC (or gel) phase and
ordering phospholipids in the LE (or liquid-crystalline) phase, resulting
in the formation of the so-called “liquid-ordered” (Lo) and “liquid-
disordered” (Ld) phases, respectively [7]. Cholesterol decreases packing
and increases the mobility of phospholipids in the ordered phase and
reduces the conformational entropy of the phospholipid acyl chains in
the disordered phase [7]. The Lo phase is more ﬂuid then the LC phase,
and the Ld phase is less ﬂuid than the LE phase (LCbLobLdbLE) [2,7].
The effect of cholesterol on lipid bilayers has been studied
extensively. Some interesting simulation studies have shed some light
on the behavior of cholesterol in bilayers. Early atomistic molecular
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Fig. 6. Radial distribution functions. An initially disordered monolayer is quenched to 283K (a). The corresponding radial distribution functions are also shown for DPPC–POPC
(b), DPPC–DPPC (c), and POPC–POPC (d) association. The RDFs are averaged from 0–10 ns (blue), 10–50 ns (green), 50–100 ns (yellow), 150–200 ns (red), and 900–1000 ns (black).
The snapshot shown was taken after 1 μs of simulation at 283K.
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condensing effect of cholesterol on thebilayer resulting in a reduction in
empty free volume and a signiﬁcant inﬂuence of cholesterol on
subnanosecond time-scale lipid dynamics including reduced center-
of-mass rattling motion and reducedmethylene reorientational motion
along the entire length of the hydrocarbon chains [75]. In amore recent
study, atomistic MD simulations revealed that in DPPC/cholesterol
bilayers high concentrations of cholesterol (~20%) change the
pressure proﬁle across the bilayer from being relatively ﬂat to an
alternating sequence of large positive and negative lateral pressures
[76]. Using a multi-state computer model Mouritsen and coworkersFig. 7. A 1024 lipid 1:1 DPPC:POPC monolayer 1 μs after being quenched to 283K from a
high temperature initially disordered state. This ﬁgure contains only a single periodic
image, unlike the previous images.[77,78] found that cholesterol exhibited anorderingeffect ondisordered
bilayers, a disordering effect on order bilayers, and displayed an afﬁnity
for domain interfaces. In addition, multi-scale simulations of lipid
bilayers combining MD and mean-ﬁeld theory showed that cholesterol
induced structural changes in thebilayer by causing local orderingof the
phospholipids aroundeachcholesterolmolecule [79]. Also, theMARTINI
model has also been used to simulate phase transitions in a bilayer
containing cholesterol with both saturated and unsaturated phospho-
lipids [80]. These simulations showed the formationof coexisting liquid-
ordered and liquid-disordered phases with structural and dynamic
properties that closely matched experimental data. Studies of mono-
layers containing cholesterol are much less prevalent. Recent atomistic
and CG simulations of small (33–36 lipids) 8:2:1 and 4:1:4 DPPC:POPG:
cholesterol monolayers at 310K and low surface tensions reported that
the addition of cholesterol resulted in a phase change of themonolayers
from an expanded to a condensed phase [47]. Our observations agree
wellwith previous simulation studies showing the condensing effects of
cholesterol on disordered monolayers and bilayers [47,77–79], the
localized ordering observed in phospholipids neighboring cholesterol
[79], and cholesterol's afﬁnity for domain boundaries [77,78]. Experi-
mental studies have also revealed that cholesterol has a marked affect
on domain shape and size due to its line active properties [81,82], which
has been interpreted as a speciﬁc binding of cholesterol to the boundary
region between condensed and ﬂuid phases [81].
In Fig. 8 snapshots are shown at selected temperatures with
corresponding RDFs showing the distribution between cholesterol
molecules and disordered C2 sites (blue), ordered C2 sites (green), and
other cholesterol molecules (red). The RDFs conﬁrm the observed
preference of cholesterol to reside at the interface. The RDFs obtained
from the ordered monolayers (Fig. 8(b)) demonstrate a stronger
association of cholesterol with the disordered sites than with the
ordered sites, as evident from the magnitude of the ﬁrst peaks in the
2459S.L. Duncan et al. / Biochimica et Biophysica Acta 1808 (2011) 2450–2465radial distribution functions. In contrast the RDFs corresponding to
disorderedmonolayers (Fig. 8(d))demonstrate a stronger associationof
cholesterol with the ordered sites than with the disordered sites. The
stronger association of cholesterol with disordered sites in a mostly
ordered monolayer and with ordered sites in a mostly disordered
monolayer reﬂects cholesterol's preference for the interface. In the
disordered monolayers (Fig. 8(d)) the ﬁrst peak in the cholesterol–
cholesterol distribution is very weak, showing that cholesterol does not
associate strongly with itself. In the ordered monolayers (Fig. 8(b)) the
self-association increases, but remains relatively weak. It is interesting
to note that the cholesterol–cholesterol RDF of the disordered
monolayer (Fig. 8(d)), which contains a substantial fraction of isolated
ordered patches, closely resembles the RDF reported for coexisting
liquid ordered and liquid disordered phases in a CG bilayer modeled
with the MARTINI force ﬁeld [80]. Whether heating from low
temperature or cooling from high temperature, little structural
differences are seen between the RDFs of two disordered monolayers
or between the RDFs of two orderedmonolayers (not shown). The RDFs
of the ordered monolayers show long-range order, while the RDFs for
the disordered monolayers show a few well-deﬁned peaks indicating
some short-range order resulting from small patches of condensed
phase.
3.5. Hydrophobic surfactant proteins
Our observations agree well with experimental observations of the
inﬂuence of surfactantpeptideson lipidpacking. SP-B, SP-B1–25 andSP-C
are known to localizewithin the ﬂuid phase [14,17,29,30,74,83–91] and
have been found to perturb monolayers of DPPC, DPPC/DPPG, and
palmitic acid (PA), increasing the overall ﬂuidity of themonolayers and
producing smaller and more numerous condensed phase domains(a)
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Fig. 8. Radial distribution functions for DPPC/cholesterol monolayers. Snapshots and corre
initially ordered monolayer heated to 303K and 328K, respectively. In the radial distributio
and cholesterol–cholesterol (red) distributions are shown. The snapshots were obtained af[14,17,29,83,92,85,86]. Fluorescence and scanning force microscopy
report that SP-B affects the distribution of LE and LC regions of DPPC at
both themicroscopic and nanoscopic level causing an overall reduction
in the total amount of LC phase present and an increase in the LC–LE
interface [17]. It has therefore been hypothesized that SP-B promotes
the formation of a ﬁne nanoscopic framework of lipid and lipid–protein
nano-domains, which may lend the ﬁlm both structural stability and
dynamic ﬂexibility. SP-B has also been observed to segregate and form
clusters at phase boundaries [17]. Our simulations show that SP-B1–25
perturbs the packing of the neighboring lipids. Also, the peptides tend to
localize and aggregatewithin a single LE phase domain. The aggregation
seen in our simulations agrees well with the experimental observation
of SP-B clusters at domain boundaries. However, the domain sizes in our
simulations are too small to say whether the SP-B aggregates prefer
phase boundaries over the bulk LE phase.
To further evaluate the affect of the peptides on the monolayer, a
larger system was generated from the disordered starting state by
copying the box laterally to create a system containing four times as
many molecules as the original system. After 1 μ s of simulation at
303K, these larger monolayers show a large amount of LC phase with
some LE phase centered around the peptides. The peptides disrupt the
crystallinity of the ordered phase and act as defects in the monolayer.
In order to propagate the LC phase must grow into peptide-free
regions of the monolayer, this growth essentially pushes the peptides
together uniting them within the small fraction of disordered phase
(Fig. 9). This type of behavior may explain why SP-B has been
observed to aggregate experimentally. Furthermore, the fact that the
peptide impedes the spread of ordered domainmay explain, at least in
part, why the peptides have been observed at domain boundaries.
Simulations containing larger LE domains in coexistence with the LC
phase, would help to provide more deﬁnitive results regarding the0 1 2 3 4 5
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n functions (c,d) the cholesterol-ordered C2 (green), cholesterol-disordered C2 (blue),
ter 1 μs of simulation. The RDFs are averaged over the last 500 ns of simulation.
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simulations would be computationally expensive and are not yet
practical. From Fig. 9, it is apparent that the peptide-ﬁlled LE phase
breaks up the condensed phase. This behavior is in consensus with the
proposed role of SP-B1–25 in the formation of a ﬁne nanoscopic
framework.
3.5.1. Effect of initial position
To test the dependence of the domain formation on the initial
position of the peptides, three different initial conﬁgurationswere used.
As described in the Simulation methods section, four peptides were
placed partially inserted in each monolayer so that they formed a
square, a line, and a cluster, with respect to each other. All snapshots in
Figs. 1 and 2 correspond to the line initial conﬁguration. In Fig. 10, the
monolayers with the line (left) initial conﬁguration are reproduced
alongside corresponding simulations with the square (center) and
cluster (right) initial conﬁgurations. The snapshots shown were taken
after 1 μ s of simulation for the line and square initial conﬁgurations and
after 100 ns of simulation time for the cluster initial conﬁguration. Note
that the simulations involving the cluster initial conﬁguration were
limited to 100 ns because the onset of fold nucleation around the
peptide aggregate limited access to longer simulation times. The
observed fold nucleation has been discussed previously [37]. The
snapshots shownwere taken at 303K after quenching from a disordered
state (top) and heating fromanordered state (bottom). The simulations
with the square initial conﬁguration result in similar amounts of LC and
LE phase lipids as the line initial conﬁguration. However, the amount of
LC phase is slightly greater in the monolayer where the peptides were
initially clustered together. These simulations show that condensed
phase formation is perturbedby the insertion of peptides, and the extent
of perturbation depends on the position of the peptides relative to one
another. The peptides perturb the surrounding lipids, and therefore if
the peptides are clustered together, the LCphase is only perturbed in the
immediate vicinity of the peptide cluster andmost of the LC phase is left
unaffected. In fact, the total amount of LE phase lipids at 303K is roughly
the same in the cluster conﬁguration (Fig. 10(c) and (f)) as in the pure
lipid system(Figs. 1 and2).However, if thepeptides are spreadout (as is
the case for the line and square starting states), the LE phase surrounds
the peptides, coveringmore area and decreasing the total amount of LC
phase present in the monolayer. Therefore, the growth of the LC phase
favors the aggregation of the peptides.
3.5.2. Hydrophobic surfactant protein SP-C
A limited number of simulations were also performed for mono-
layers containing SP-C. To correspond with experimental observations,
SP-C was placed initially tilted and embedded in the DPPC monolayer
[56]. Using the line initial conﬁguration, disordered and ordered starting
states forDPPC/SP-Cmonolayerswere generated in the samemanner as
the starting states for the DPPC/SP-B1–25 monolayers. Simulations were(a) (b)
Fig. 9. Packing in monolayers composed of 1024 DPPC with 16 SP-B1–25 molecules. A high t
were taken after (a) 10 ns, (b) 100 ns, and (c) 1 μs of simulation time.performed at 303Kand308Kusingboth initially ordered anddisordered
starting states. At 303K both starting states resulted in ordered
monolayers after 1 μ s of simulation (not shown). However, hysteresis
is evident at 308K. After 1 μ s at 308K, the initially disorderedmonolayer
remains disordered (Fig. 11(a)) and the initially ordered monolayer
remains ordered (Fig. 11(b)). It is unclear why initially ordered DPPC/
SP-C monolayers remain ordered at 308K, where DPPC/SP-B1–25
monolayers disorder (Fig. 2). To further elucidate this difference in
phase behavior at 308K, the DPPC/SP-C (Fig. 11(c)) and DPPC/SP-B1–25
(Fig. 11(d))monolayers are visualized from the side. This shows that SP-
C penetrates deeper into the monolayer than does SP-B1–25. However,
the SP-B1–25 containing monolayer shows substantial deformation
around the SP-B1–25 aggregate, resembling a pre-collapse instability.
The observed difference in the phase behavior of the SP-C and SP-B1–25
containingmonolayersmay be linked to the curvature of themonolayer
near the peptide, and requires further investigation beyond the scope of
this paper.
It is also interesting to note that in Fig. 11(c), the palmitoyl chains of
SP-C (shown in red) remain ﬁrmly embedded within the monolayer. It
has been proposed that at high surface pressures (low surface tension)
SP-C is partially squeezed-out of the monolayer with associated lipids,
but remainsanchored to themonolayer interfaceby its palmitoyl chains,
which remain embedded within the monolayer [36,87–90,93,94].3.6. Implications of phase behavior on partial collapse at high surface
pressure
Classical squeeze-out theory predates knowledge of surfactant
proteins. In recent years, squeeze-out theory has been revised to
suggest the existence of a protein associated surfactant reservoir, which
stores material removed from the interface upon compression near the
interface where it is readily available for reinsertion upon expansion.
Several studies have reported evidence of peptide associated partial
collapse structures, which may act as reservoirs [4,29,30,83–97]. It
should be noted that these studies do not necessarily suggest
enrichment of the monolayer in DPPC, as suggested by classical
squeeze-out theory. These protein partial collapse structures have
been observed to originate from the LE phase [4,30,84–90]. In thiswork,
lung surfactant peptides are clearly excluded from the condensed phase
and reside within the ﬂuid phase. This is consistent the appearance of
peptide-associatedpartial collapse structureswithin theﬂuidphase. Ina
previous paper, we assessed the role of lung surfactant components on
collapse [37]. One of the key ﬁndings of this paper is the peptide-
mediated nucleation of small collapse structures, which are comparable
to those identiﬁed experimentally. These results along with the results
presented here paint a picture that is consistent with revised squeeze-
out theory, and suggest an important role for SP-B and SP-C. The lungs
surfactant proteins appear to act as a catalyst, destabilizing the(c)
emperature initially disordered monolayer is quenched to 303K. The snapshots shown
(a) (b) (c)
(d) (e) (f)
Fig. 10. The inﬂuence of peptide orientation on the LC–LE phase coexistence. Three peptide initial orientations were studied: line (left), square (center), and cluster (right).
The snapshots were taken after 1 μs of simulation at 303K, with the exception of cluster conﬁguration, which was taken after 100 ns of simulation time. The monolayers on the top
were quenched from a disordered state and the monolayers on the bottom were heated from an ordered state.
(a) (b)
(c) (d)
Fig. 11. The phase behavior of monolayers containing SP-C. After 1 μs of simulation at
308K, the initially disordered DPPC/SP-C monolayers remain disordered (a) and the
initially ordered DPPC/SP-C monolayers remain ordered (b). Side views are also given
to elucidate the difference between initially ordered SP-C (c) and SP-B1–25
(d) containing monolayers after 1 μs of simulation at 308K. In (c) and (d) the peptides
are shown in yellow, the palmitoyl chains of SP-C are shown in red, and the CG water
molecules are shown as small white dots. The DPPC tails, headgroups, and glycerol
linkages are shown in turquoise, dark blue, and green, respectively. To clearly visualize
the depth of the peptide penetration into the monolayer, the C2 sites of the
phospholipid tails are enlarged with respect to the rest of the phospholipid sites.
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transitions.
It has been suggested that partial collapse structures should have
the same composition as the phase from which they are formed [98].
The peptide enrichment of LE phase observed here and the known
association between peptides and collapse structures both suggest
that the collapse structures may be enriched in surfactant proteins.
Collapse structures have also been observed to preferentially associate
with domain boundaries [4]. This could suggest that components,
which exhibit a preference for domain boundaries may also be
enriched in the collapse phase. Here we observe a clear preference of
cholesterol for the interface. This observation agrees with experi-
mentally observed line-active properties of cholesterol [81,82]. If both
cholesterol and collapse structures exhibit a preference for domain
boundaries, the concentration of cholesterol would likely have a direct
inﬂuence on the existence and number of partial collapse structures.
In fact such and affect has been observed. In a recent experimental
study revealed that the addition of 10 mol% cholesterol resulted in an
increase in the number and size of protrusions [99]. However, large
amounts of cholesterol (30 mol%), increased monolayer rigidity and
prevented the formation of partial collapse structures. The direct
inﬂuence of cholesterol on the existence and number of partial
collapse structures may be attributed in part to the preference of both
cholesterol and collapse structures for the interface.
We do not observe any evidence for supercompression. However,
there are physiological complexities (i.e. structural changes and
heterogeneous phase and composition) that are not fully accounted
for by simulation. It remains unclear if the physiological stability of lung
surfactant at high surface pressures is attributed to a combination of
phase and partial collapse transitions or to supercompression.
3.7. Nucleation and growth and transition temperature
The 1 μ s simulations of DPPC monolayers lead to a large amount of
hysteresis,with the LC–LEphase transition occurring between303Kand
323K. To obtain a better approximation of the true transition
temperature of our DPPC monolayers, several simulations were run
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described in the Simulationmethods section. In short, two systemswere
constructed, Merge1 and Merge2. To attain the proper alignment
between the ordered anddisordered systems, the disorderedmonolayer
was condensedby0.7 nm in they-direction inMerge1 and inMerge2 the
width of ordered box was increased by 0.7 nm in the y-direction. The
starting conﬁguration for Merge2 is shown in Fig. 12(a). The starting
conﬁguration for Merge1 (not shown) is visually similar to the
conﬁguration shown for Merge2. The extra space along the edge of the
box inMerge2 leads to the disordering of the lipids along the edge of the
box, which causes the size of the LC domain to shrink, see Fig. 12(b).
The construction of Merge1 and Merge2 established two systems
with a well-deﬁned front between the ordered and disordered phases,
making them ideal systems for the studyof thenucleation and growthof
LC phase and also the melting of the LC phase. For example, in
Fig. 12(a–f) the simulation of Merge2 at 310K is shown. Once the
simulation is started, the size of the LC phase domain quickly shrinks
(Fig. 12(b)) due to disordering of the lipids along the edge of the box
associated with the introduction of extra space into this system. After
the initial shrinkage, the ordered phase then begins to re-grow
(Fig. 12(c,d)). After 60 ns (Fig. 12(e)) the ordered phase has propagated
across the entire box and an LE phase domain becomes entrapped. After
100 ns (Fig. 12(f)) of simulation the LE phase domain has decreased
slightly in size and additional defects are also present in the LC phase
packing. Simulations were also run at 308K, 313K, and 318K for both
Merge1 andMerge2monolayers and at 315K forMerge1monolayers. At
308K the monolayers in both systems (Merge1 and Merge2) order,
while at 318Kboth systemsdisorder. At 313K themonolayers inMerge1
order but the monolayers in Merge2 disorder, suggesting that the
criticalnucleus for ordering is attained inMerge1andnot inMerge2. The
disruption of the packing along the edge of the box in Merge2 likely
causes the LC domain size to shrink below the critical nucleus size. At(a) (b)
(d) (e)
(g) (h)
Fig. 12.Nucleation and growth of the LC phase. The starting conﬁguration forMerge2 simulat
(a), 2 ns (b), 20 ns (c), 40 ns (d), 60 ns (e), and 100 ns (f) of simulation time. Snapshots from
simulation time.315K the ordered region of Merge1 begins to grow into the initially
disordered box (Fig. 12(g)), but then shifts so that roughly half of the
disordered box becomes ordered and roughly half disordered (Fig. 12
(h)). Packing ﬂuctuations are evident, but the relative amount of LE and
LC phases does not change signiﬁcantly for the remainder of the
simulation (Fig. 12(i)) suggesting that the coexistence of the condensed
and expanded phases is stable on the time-scale of this simulation.
These results suggest that the true transition temperature lies between
310K and 318K, and the behavior observed at 313K and 315K suggests
that these simulations are in close proximity to the actual transition
temperature.
These simulations showanucleation and growthmechanism similar
to that reported byMarrink and co-workers in their simulations of DPPC
bilayers [46]. The LC phase domains are observed to ﬂuctuate, shrinking
and growing in size. At some point a critical nucleus is obtained and the
ordered phase continues to spread. After the ordered phase propagates
some disordered lipids become entrapped. Further ordering is slow and
defects are long lived. Defect-freemonolayers are not observed over the
course of our 1 μ s simulations. As reported for DPPC bilayers [46], the
defects are long lived because the freezing of trapped disordered
domains requires global reorganization of the LC matrix.
In the reverse process, disorder originates from a defect in the
monolayer such as a disordered patch of lipids around a peptide or near
the edge of the box,where extra spacewas inserted intoMerge2. The LE
phase grows at the cost of the LC phase domain, which shrinks and
eventually disappears. As shown in Fig. 4(a), the SP-B1–25 molecules are
observed to nucleate disorder in the monolayer leading to the collapse
of the hysteresis onto the disordered side of the hysteresis loop. This
behavior may result from the high concentration of SP-B1–25 in our
simulations, which could prevent the formation of a critical nucleus.
Given that the formation of liquid condensed domains involves a
nucleation process, the large amount of hysteresis observed in our(c)
(f)
(i)
ions is shown (a). Snapshots from the simulation ofMerge2 at 310K are shown after 0 ns
the simulation of Merge1 at 315K are shown after 14 ns (g), 60 ns (h), and 100 ns (i) of
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hysteresis between melting and freezing transition temperatures for
coarse-grained DPPC bilayers [46]. They suggest that the condensed
phase can remain stable well past its transition temperature due to
kinetic trapping.3.8. Packing ﬂuctuations
To quantify the persistent changes in packing caused by instanta-
neous domain patterns, we plotted the percentage of hexagonally
packed sites versus simulation time (Fig. 13). Data for both the top (red)
and bottom (black) monolayers are shown. The ﬂuctuations in
hexagonal packing typically fall in the range of ±2–5%. The error bars
reported in Fig. 4 give the standard deviation in the percentage of
hexagonal packing for DPPC, DPPC/cholesterol, DPPC/POPC, and DPPC/
SP-B1–25 monolayers. These error bars thus reﬂect themagnitude of the
packingﬂuctuations. From the size of the error bars and from Fig. 13 it is
apparent that the ﬂuctuations are a little bit larger in the disordered
monolayers than in the orderedmonolayers. Also, the ﬂuctuations seen
in the monolayers of pure DPPC do not differ greatly from those seen in
monolayers composed of DPPC with cholesterol, POPC, or SP-B1–25.
However, the addition of a second component does result in slightly
larger ﬂuctuations in the LC phase monolayers. The magnitude of the
ﬂuctuations also increases slightly as the temperatures approach the
transition temperature on either side of the hysteresis loop.
In most of our simulations, phase transitions occur within the ﬁrst
500 ns of simulation. However, the monolayers are meta-stable, and
long simulation times increase the probability of the development of a
critical nucleus. Therefore, the size of the hysteresis loop is a function of
simulation time. For DPPCmonolayers at 323K the transition from LC to
LEphase occurs after 700 ns of simulation time, as shown in Fig. 13. Both
the top andbottommonolayers undergo the transition at the same time,
due to coupling between the two monolayers, produced by the
shrinkage of the lateral dimensions of the box that occur upon ordering.
The ﬂuctuations observed in our simulations are analogous to
hetero-phase ﬂuctuations reported in lipid bilayers near the main
transition temperature [46]. There are also a limited number of
simulation studies discussing ﬂuctuations observed in the phase
transitions of monolayers. Using a multi-state computer model,500 600 700 800 900 1000
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Fig. 13. Packing ﬂuctuations. Characteristic packing ﬂuctuations are shown here for
pure DPPC monolayers heated from an initially ordered state (283K) to 323K. Both the
top (red) and bottom (black) monolayers are shown. The ﬂuctuations shown here are
similar to those seen in all of our simulations, which vary slightly in magnitude. Most of
our simulations that undergo a phase transition do so before 500 ns of simulation time.
However, phase transitions can occur at later times as shown here.Mouritsen et al. [100] found that thermally induced density ﬂuctuations
led to inhomogeneous micro-states and instantaneous lipid domain
patterns in monolayers. They attribute the slow relaxation process to
kinetic stabilization of the domain interfaces by intermediate confor-
mational states, which lower the interfacial tension, analogous to
softening observed in lipid bilayers. Mouritsen and coworkers [78] also
applied a multi-state computer model to study ﬂuctuations in DPPC
bilayers. In these simulations domains, which ﬂuctuated in size and
position,were observedover a rangeof temperatures near the transition
temperature. The domains increased in size as the transition temper-
ature was approached.
3.9. System size effects and simulation time
As discussed previously [11,37], system-size and simulation-time
artifacts should be carefully considered. This is especially true when
phase transitions are involved. Simulating a biphasic system raises
additional concerns about artifacts. When the box is split between
phases each domain is further limited in size. Also short simulation
time-scales will be associated with kinetic effects. However kinetic
effects are also present in experiment (although to a lesser degree), as
discussed previously [11], and physiological surfactant function is also
dynamic in nature, and as such is subject to kinetic factors. While the
equilibriumdomainmorphology is determined by the balance between
line tension and long range dipole–dipole repulsion, the actual
(experimental and physiological) domain morphology is normally
determined by kinetic factors, since true equilibrium between phases in
a monolayer is established very slowly, see [4] and references therein.
Therefore, experimental phase distributions depend on compression
rate, with fast compression resulting in smaller domains [4].
Hysteresis is expected to decrease with increased simulation times
or larger system sizes. Previous CG-MD simulations of the gel to liquid-
crystalline phase transitions in DPPC bilayers have shown that the
hysteresis observed in the freezing and melting transitions depends on
both system size and time-scale [46]. Previous CG-MD simulations of
pressure-area isotherms of DPPC monolayers have also shown that
increasing the system size decreases the hysteresis loop [11]. Here a
comparison of hysteresis loops obtained from 1 μ s and 100 ns
simulations of DPPC monolayers (Fig. 14) reveals a substantial change
in hysteresis. As noted previously [46], the transition is triggered by a
critical ﬂuctuation, which is more likely to occur given a larger system
size or a longer simulation time.
Beyond their effect on hysteresis, it is unclearwhat additional effects
system size and simulation timemay have on the evolution of the phase
distribution. For instance, given long enough simulation times, domain
coarsening may occur within the LC phase of the CG 1:1 DPPC:POPC
monolayer, and given a larger system size SP-B1–25 could display a
preference for the interfacebetween the LE and LCphase. Unfortunately,
the system size and time scales required to attain an equilibrium
distribution of LC and LE phases are much larger than that currently
accessible by molecular simulation. Although CG simulation is still
limited by system size and simulation time effects, it does allow
observation of dynamic phase transitions on time and length scales not
yet readily accessible by atomistic simulation, whose time and distance
windows are too small, or experiment, whose resolution is not small
enough.
4. Summary
Using the MARTINI model, we simulated LC–LE phase transitions in
monolayers containing DPPC and additional lipid or peptide compo-
nents.Our analysis ofDPPCmonolayers suggests that theLCphase forms
via a nucleation and growth mechanism analogous to that observed in
lipid bilayers. In the reverse process, the melting of the LC phase is
observed to originate at defects in the monolayer. Both POPC and
SP-B1–25 are found to ﬂuidize the monolayer. In correlation with
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Fig. 14.Hysteresis in pure DPPCmonolayers for simulations run for 1000 ns (black) and
100 ns (red) at each temperature.
2464 S.L. Duncan et al. / Biochimica et Biophysica Acta 1808 (2011) 2450–2465experimental observations SP-B1–25 is found to reside in the LE phase of
the monolayer. SP-B1–25 is also observed to perturb the packing of the
surrounding lipids leading to local ﬂuidization of the monolayer.
The presence of POPC spread throughout the monolayer prohibits the
DPPC condensed-phase domains from nucleating at higher tempera-
tures. At low temperatures, both POPC and DPPC condense. The
segregation of the two lipids is observed in the condensed phase, but
not in the expandedphase. TheDPPC–cholesterolmonolayers are found
to display a phase of intermediate order, which could be the liquid-
disordered (Ld) phase. The hysteresis loop for DPPC–cholesterol
monolayers is shifted up slightly compared to the hysteresis loop for
pure DPPC, suggesting that the addition of cholesterol results in an
increase in the transition temperature and stabilization of the
condensed phase. Cholesterol shows a preference for the interface
between the ordered and disordered lipids, in agreementwith previous
simulation results. DPPC displays a substantial amount of hysteresis,
which is decreased by the addition of a second component. While the
addition of cholesterol or POPC decreases the hysteresis loop, the
addition of SP-B1–25 abolishes the hysteresis loop altogether. SP-B1–25
nucleates disorder causing the disappearance of the ordered side of the
hysteresis loop. These results suggest that the presence of impurities in
the monolayer (such as SP-B1–25) may obviate the need for ﬂuctuations
to produce a critical nucleus for a disordering transition. These results
illustrate that coarse-grained molecular dynamics simulation is a
powerful tool for investigating the dynamic phase behavior of lipid
and lipid–peptide monolayers on length scales not accessible by
experimental methods or atomistic simulation.
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